OrbiMed
About Us | Novartis Venture Fund
Adicet Bio | Gamma Delta T cells | Off the-shelf T cell therapy
Description: Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases.
Universal off-the-shelf T cell therapy for cancer
Gamma delta T cells represent a new generation of universal immune cell therapy
Learn More
OrbiMed
About Us | Novartis Venture Fund
Adicet Bio | Gamma Delta T cells | Off the-shelf T cell therapy